The associations between serum biomarkers and stenosis of the coronary arteries

Lei Feng1,2,3, Shiyan Nian4, Shu Zhang3

  • 1Department of Laboratory, People's Hospital of Yuxi City, Yuxi City, Yunnan, P.R. China.

Oncotarget
|June 3, 2016
PubMed

Insights

Serum biomarkers correlate with coronary artery stenosis severity. Key indicators like age, HDL, LDL, Lp(a), and HCY show gender-specific associations with the number of blocked coronary arteries.

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Medical Diagnostics

Background:

  • Serum biochemical indices offer insights into physiological and pathophysiological states.
  • The relationship between serum markers and coronary artery stenosis extent is under-researched.

Purpose of the Study:

  • To investigate the association patterns between serum biochemical markers and the number of stenotic coronary arteries.
  • To identify gender-specific risk factors for coronary artery stenosis.

Main Methods:

  • Cross-sectional study involving 627 healthy controls and 1,049 coronary heart disease (CHD) patients.
  • Binary and ordinal multiple logistic regression analyses were employed to evaluate associations.
  • Serum biochemical markers were analyzed in relation to the number of stenotic coronary arteries.

Main Results:

  • Age, high-density lipoprotein cholesterol (HDL), and homocysteine (HCY) were common risk factors for CHD in both genders.
  • In males, increasing stenosis correlated with higher age, low-density lipoprotein cholesterol (LDL), and lipoprotein (Lp(a)), and lower HDL.
  • In females, stenosis correlated positively with age and Lp(a), and negatively with total bilirubin (TBil). Age and Lp(a) were common positive risk factors, while HDL and LDL were male-specific, and TBil was female-specific.

Conclusions:

  • Serum biomarker levels are correlated with the number of stenotic coronary arteries.
  • These correlations exhibit distinct gender-based patterns, highlighting the importance of sex-specific analysis in cardiovascular risk assessment.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
717
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.5K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
389
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
526
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
653